Stocks on the move: FL, GPS, AMAT >>> READ MORE


Recent Articles

Why Vertex Pharmaceuticals Incorporated (VRTX) Stock Isn’t Worth the Risk

Vertex Pharmaceuticals is backed by incredible scientific innovations, but VRTX stock is still a gamble on a single, flagship treatment plan. More 

Why Vertex Pharmaceuticals Incorporated (VRTX) Will Keep Rolling Higher

Vertex Pharmaceuticals (VRTX) is on its way to becoming the Gilead of cystic fibrosis, which could mean solid gains for VRTX stock. More 

Should You Buy Vertex Pharmaceuticals Incorporated (VRTX) Stock? 3 Pros, 3 Cons

Vertex continues to extend its dominance within cystic fibrosis treatments. But has VRTX stock run ahead of the company's potential? More 

Buy Vertex Pharmaceuticals Incorporated (VRTX) Stock Like Its 20% Gain Never Happened

Chasing a 20% spike in Vertex Pharma (VRTX) may seem reckless, but the options market is the closest thing to a time machine in VRTX stock. More 

3 Stocks to Watch on Wednesday: Vertex Pharmaceuticals Incorporated (VRTX), CSX Corporation (CSX) and International Business Machines Corp. (IBM)

Vertex Pharmaceuticals (VRTX) soars on cystic fibrosis treatment data, CSX Corporation (CSX) falls on a restructuring charge and International Business Machines (IBM) refuses to grow. More 

Wall Street’s 5 Hottest Biotech Stocks Right Now

These five top biotech stocks have the seal of approval from the Street, with 'strong buy' analyst consensus ratings and big upside. More 

The 10 Best S&P 500 Stocks Through 2017’s First Half

The 10 best S&P 500 stocks through the first six months of 2017 are a diverse bunch that span six of the index's 10 sectors. More